MDMA-Assisted Massed Exposure Therapy for PTSD
Phase 2
200
about 4 years
21–70
1 site in GA
What this study is about
Researchers are testing if MDMA combined with Massed Prolonged Exposure (PE) therapy helps people with PTSD. The trial will compare this treatment to PE alone, and a placebo. The goal is to see if the combination of MDMA and PE leads to better results than just PE or a placebo in reducing PTSD symptoms.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Participate in Massed Prolonged Exposure (PE)
- 2.Take 3,4-Methylenedioxymethamphetamine (MDMA)
- 3.Take Placebo
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
oral
Primary: Changes in PTSD symptoms measured by CAPS-5-R
Secondary: Changes in PTSD symptoms measured by PCL-5
Psychiatry / Mental Health